search
Back to results

SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer

Primary Purpose

Cancer, COVID

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Exercise
Psychological and Behaviour Change Support
Nutrition
Sponsored by
University Hospital Southampton NHS Foundation Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cancer focused on measuring COVID-19, Virtual clinics, Exercise, Cancer diagnosis, Nutrition, Psychological support, Behaviour change

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male or female participants, aged over 18 years old
  • Suspicion or confirmed diagnosis of cancer (does not require histological confirmation)

Exclusion Criteria:

- Participants unable to give informed consent

Sites / Locations

  • University Hospital Southampton NHS FTRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Universal Interventions

Arm Description

The delivery of nutrition, exercise and psychological interventions delivered in the following structure: Month 1: Up to three times per week Months 2-3: Once per week Months 4 - 6: One session per month for the last 3 months

Outcomes

Primary Outcome Measures

Physical Function
Physical function will be measured using the EORTC-QLQ-C30. Participants will choose from the choices 1 = Not at all; 2 = A little, 3 = Quite a bit, 4 = Very much

Secondary Outcome Measures

Emotional Function
Emotional function will be measured using the EORTC-QLQ-C30. Participants will choose from the choices 1 = Not at all; 2 = A little, 3 = Quite a bit, 4 = Very much
Health related quality of life
EQ-5D-5L is a standardised measure of health status developed by the EuroQol Group. Applicable to a wide range of health conditions and treatments, it provides a simple descriptive profile and a single index value for health status that can be used in the clinical evaluation of health care
Health economics analysis
EQ-5D-5L is a standardised measure of health status developed by the EuroQol Group. Applicable to a wide range of health conditions and treatments, it provides a simple descriptive profile and a single index value for health status that can be used in the economic evaluation of health care
Patient activation
Patients knowledge skills and confidence to manage their own health and care will be measured using the Patient Activation Measure (PAM) Agreement or disagreement with statements. Choice between disagree strongly, disagree, agree, agree strongly and not applicable
Self-reported physical activity
Measured using the Godin Leisure Time Exercise Questionnaire, a 7-day physical activity recall
Nutrition assessment
In the oncology population where malnutrition prevalence is high, the Patient-Generated Subjective Global Assessment Short Form (PG-SGA SF) is a descriptive screening tool that can provide further information to assist triaging and capture acute change in nutritional state
Self-efficacy for self-management of chronic disease
Self-efficacy (confidence) to self-manage chronic disease (SEMCD), measured using the Lorig SEMCD scale A confidence scale that represents the patients confidence that a regular task can be achieved. 1 = Not confident at all and 10= totally confident.
Distress levels
Levels of distress as measured by the Emotions Thermometers. Participants will score on a scale where 0 = None and 10 = Extreme
Functional capacity
The Dukes Activity Status Index is a 12 item self-report measure of functional capacity that can be used to estimate peak oxygen uptake
The impact of COVID-19 pandemic on psychological functioning
As measured by the Impact of Event Scale - a 22-item self-report measure of the imapact of a specific traumatic event against the DSM criteria for Post Traumatic Stress Disorder. 0 = Not at all and 4 = Extremely.
Process Evaluation
Semi-structured interviews with participants and professionals to explore acceptability, usefulness and barriers to delivery/engagement

Full Information

First Posted
June 3, 2020
Last Updated
June 7, 2022
Sponsor
University Hospital Southampton NHS Foundation Trust
Collaborators
Macmillan Cancer Support, CanRehab Trust, Wessex Cancer Alliance
search

1. Study Identification

Unique Protocol Identification Number
NCT04425616
Brief Title
SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer
Official Title
SafeFit Trial: Virtual Clinics to Deliver Universal Interventions to Maintain and Improve Mental and Physical Health in People With Cancer Who Are Following Social Distancing Guidance: A COVID-19 Targeted Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 4, 2020 (Actual)
Primary Completion Date
June 30, 2023 (Anticipated)
Study Completion Date
December 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital Southampton NHS Foundation Trust
Collaborators
Macmillan Cancer Support, CanRehab Trust, Wessex Cancer Alliance

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Trial Phase: Phase III: Interventional Trial: Virtual clinics to deliver universal interventions to maintain and improve physical health, nutritional state and psychological wellbeing in people with cancer who are following social distancing guidance: A COVID-19 targeted trial. Indication: Male or female participants, aged over 18 years old with suspicion or confirmed diagnosis of cancer (does not require histological confirmation) Objective: To investigate the efficacy of remote multimodal universal interventions delivered via virtual clinics to improve physical function as measured by the EORTC-QLQ-C30. Secondary Objective: To investigate the efficacy of remote multimodal universal interventions delivered via virtual clinics to improve emotional function, quality of life, participant activation (PAM), behaviour change and the effect it has on health economics (EQ-5D-5L). Exploratory Objective: Overall Survival and adherence to the intervention/advice using validated tools or development of a web-based toolkit.
Detailed Description
Rationale: A recent statement by Professor Chris Whitty, Chief Medical Officer, NHS England, emphasised the significant benefits of exercise for all people. He said, "this may be challenging for people self-isolating and even more so for those highly vulnerable people that are having to shield against the virus in their own homes" The coronavirus (COVID-19) pandemic has led to many changes to everyday life including the introduction of social distancing as well as restriction of travel. Treatment plans for patients with cancer are being revised or modified due to risks and benefits of certain treatments in light of the COVID-19 risk. The number of deaths due to the disruption in cancer services is likely to outweigh the number of deaths from coronavirus itself over the next five years. The effects of this pandemic has reportedly led to increased anxiety and distress and risks deconditioning due to reduced physical activity. The interventions we are proposing aim to enable people with cancer to optimise their physical health, nutritional state and psychological wellbeing and prepare for their treatment pathway (current or modified) and recovery during this uncertain time through exercise, nutrition and psychological support. The aim is to investigate whether the promotion of these interventions delivered via virtual clinics, in socially distanced people with cancer, can improve physical and psychological function and self-efficacy to self-manage. We are also aiming to evaluate health economics whilst following the COVID-19 government guidelines. Trial Design: Phase III: Non randomised Interventional Trial Sample Size: 1100 Intervention: Provision of dietary, exercise and psychological advice as well as behaviour change support (universal interventions) as aligned to the universal interventions (with the caveats of COVID-19) in the Macmillan 'Principles and guidance for prehabilitation within the management and support of people with cancer' guideline. This complex intervention will be prescribed and delivered through virtual clinics where CanRehab professionals will support the individual. Level 3 Personal Trainers may also deliver the interventions in some cases with a GP referral qualification and who are competent in delivering the interventions to participants with cancer post-treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer, COVID
Keywords
COVID-19, Virtual clinics, Exercise, Cancer diagnosis, Nutrition, Psychological support, Behaviour change

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Non-randomised phase III interventional trial
Masking
None (Open Label)
Allocation
N/A
Enrollment
1100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Universal Interventions
Arm Type
Experimental
Arm Description
The delivery of nutrition, exercise and psychological interventions delivered in the following structure: Month 1: Up to three times per week Months 2-3: Once per week Months 4 - 6: One session per month for the last 3 months
Intervention Type
Other
Intervention Name(s)
Exercise
Intervention Description
At least one and up to three supervised sessions per week including: aerobic exercise at a rating of perceived exertion of 11-14 (6-20 scale) accumulating 20 minutes per session resistance exercise of 8-10 exercises for 2x 8-15 repetitions performed in a controlled manner and covering the whole body Range of motion exercise performed through pain free range of motion covering the whole body to be maintained in good alignment for 10-30 seconds, with some movements held for a second set of 10-30 seconds if stiff
Intervention Type
Behavioral
Intervention Name(s)
Psychological and Behaviour Change Support
Intervention Description
Instructors will be trained in Healthy Conversation Skills (HCS), Making Every Contact Count (MECC) or equivalent. This will enable them to deliver brief participant centred empowering interventions informed by social cognitive theory. This skill set will be used to support participants in adopting and maintaining the prescribed exercise and diet programme as well as adopting and practicing strategies to self-manage psychological well-being. Participants will be given the option to be provided with a SMARTER goal setting sheet to assist with goal planning. Applicable standardised psychological support resources will be made available to the participants though the Macmillan resource repository that they can access online or in alternative format as necessary, for example relaxation and mindfulness exercises
Intervention Type
Other
Intervention Name(s)
Nutrition
Intervention Description
Instructors will receive training in generic nutritional principles in line with recommendations from World Cancer Research Fund (WCRF) and British Dietetic Association, and will work with participant to review own diet and eating habits against WCRF recommendations to enable goal setting and identify links to existing resources reputable websites, outputs and on-line forums. These would include: principles of healthy eating ('eat well' advice), weight management, symptom management, prehab advice before treatment starts, rehab advice during and after treatment. The participant will be asked if they are eating and drinking well or have any concerns at the beginning of each exercise session. Further support will be provided to instructors to address participant concerns or requests for additional information.
Primary Outcome Measure Information:
Title
Physical Function
Description
Physical function will be measured using the EORTC-QLQ-C30. Participants will choose from the choices 1 = Not at all; 2 = A little, 3 = Quite a bit, 4 = Very much
Time Frame
Baseline up to 1 year post enrolment
Secondary Outcome Measure Information:
Title
Emotional Function
Description
Emotional function will be measured using the EORTC-QLQ-C30. Participants will choose from the choices 1 = Not at all; 2 = A little, 3 = Quite a bit, 4 = Very much
Time Frame
Baseline up to 1 year post enrolment
Title
Health related quality of life
Description
EQ-5D-5L is a standardised measure of health status developed by the EuroQol Group. Applicable to a wide range of health conditions and treatments, it provides a simple descriptive profile and a single index value for health status that can be used in the clinical evaluation of health care
Time Frame
Baseline up to 1 year post enrolment
Title
Health economics analysis
Description
EQ-5D-5L is a standardised measure of health status developed by the EuroQol Group. Applicable to a wide range of health conditions and treatments, it provides a simple descriptive profile and a single index value for health status that can be used in the economic evaluation of health care
Time Frame
Baseline up to 1 year post enrolment
Title
Patient activation
Description
Patients knowledge skills and confidence to manage their own health and care will be measured using the Patient Activation Measure (PAM) Agreement or disagreement with statements. Choice between disagree strongly, disagree, agree, agree strongly and not applicable
Time Frame
Baseline up to 1 year post enrolment
Title
Self-reported physical activity
Description
Measured using the Godin Leisure Time Exercise Questionnaire, a 7-day physical activity recall
Time Frame
Baseline up to 1 year post enrolment
Title
Nutrition assessment
Description
In the oncology population where malnutrition prevalence is high, the Patient-Generated Subjective Global Assessment Short Form (PG-SGA SF) is a descriptive screening tool that can provide further information to assist triaging and capture acute change in nutritional state
Time Frame
Baseline up to 1 year post enrolment
Title
Self-efficacy for self-management of chronic disease
Description
Self-efficacy (confidence) to self-manage chronic disease (SEMCD), measured using the Lorig SEMCD scale A confidence scale that represents the patients confidence that a regular task can be achieved. 1 = Not confident at all and 10= totally confident.
Time Frame
Baseline up to 1 year post enrolment
Title
Distress levels
Description
Levels of distress as measured by the Emotions Thermometers. Participants will score on a scale where 0 = None and 10 = Extreme
Time Frame
Baseline up to 1 year post enrolment
Title
Functional capacity
Description
The Dukes Activity Status Index is a 12 item self-report measure of functional capacity that can be used to estimate peak oxygen uptake
Time Frame
Baseline up to 1 year post enrolment
Title
The impact of COVID-19 pandemic on psychological functioning
Description
As measured by the Impact of Event Scale - a 22-item self-report measure of the imapact of a specific traumatic event against the DSM criteria for Post Traumatic Stress Disorder. 0 = Not at all and 4 = Extremely.
Time Frame
Baseline up to 1 year post enrolment
Title
Process Evaluation
Description
Semi-structured interviews with participants and professionals to explore acceptability, usefulness and barriers to delivery/engagement
Time Frame
Through study completion, an average of 12 months
Other Pre-specified Outcome Measures:
Title
Exploratory: Overall survival
Description
Overall survival at 1 year following date of enrolment
Time Frame
1 year post enrolment
Title
Exploratory: Adherence to the interventions/advice
Description
Adherence to intervention advice is defined as number of sessions the participants attends divided by the total number of sessions.
Time Frame
Baseline up to 1 year post enrolment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female participants, aged over 18 years old Suspicion or confirmed diagnosis of cancer (does not require histological confirmation) Exclusion Criteria: - Participants unable to give informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sandy Jack, pHD
Phone
02381205308
Email
s.jack@soton.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Samantha Leggett, BSc
Phone
02381208519
Email
samantha.leggett@uhs.nhs.uk
Facility Information:
Facility Name
University Hospital Southampton NHS FT
City
Southampton
ZIP/Postal Code
SO16 6YD
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sandy Jack, PhD
Phone
02381205308
Email
s.jack@soton.ac.uk

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34446487
Citation
Grimmett C, Bates A, West M, Leggett S, Varkonyi-Sepp J, Campbell A, Davis J, Wootton S, Shaw C, Barlow R, Ashcroft J, Scott A, Moyes H, Hawkins L, Levett DZH, Williams F, Grocott MPW, Jack S. SafeFit Trial: virtual clinics to deliver a multimodal intervention to improve psychological and physical well-being in people with cancer. Protocol of a COVID-19 targeted non-randomised phase III trial. BMJ Open. 2021 Aug 26;11(8):e048175. doi: 10.1136/bmjopen-2020-048175.
Results Reference
derived

Learn more about this trial

SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer

We'll reach out to this number within 24 hrs